Clinical Trial Update: An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures [Phase 3]

View source ↗

Summary

An open-label extension of a Phase 3 study evaluating the safety and tolerability of add-on carisbamate in patients with partial-onset seizures; the update focu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Epilepsy, Partial, Motor, Epilepsy, Complex Partial | Phase 3 | Status: COMPLETED